Barclays analyst Peter Lawson maintains Arvinas (NASDAQ:ARVN) with a Overweight and lowers the price target from $90 to $70.
Raymond James Thinks Bath & Body Works ‘Makes A Lot Of Scents’
Raymond James analyst Olivia Tong initiated coverage on Bath & Body Works Inc (NYSE:BBWI) with a Strong Buy rating and a price target of…